The FDA granted regenerative medicine advanced therapy designation to RTx-015 for the treatment of retinitis pigmentosa.

RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...

Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company pioneering optogenetic therapies for those living with ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that the U.S.

Researchers are pushing the boundaries of what “restoring sight” can mean, not only through surgical implants or gene editing but also through software that reshapes how the brain interprets what the ...

BCVA can remain deceptively stable until late RP and becomes insensitive at profound vision loss, motivating ...

A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...

Age-related macular degeneration (AMD) gradually affects central vision in one or both eyes while leaving peripheral vision (on the sides) intact. This peripheral vision – encompassing everything you ...

Over 24 months, patients with dry age‑related macular degeneration (AMD) who received light therapy with three wavelengths gained clarity of vision, had a reduced incidence of new geographic atrophy, ...

Please provide your email address to receive an email when new articles are posted on . Optometrists sometimes suggest vision therapy to improve visual skills, addressing perceptual vision and myopia.

With a multi-institutional team of engineers, optometrists, vision researchers, sports medicine physicians and biostatisticians, NJIT's Tara Alvarez set out four years ago to gather data that could ...